Commentary · 21 Feb 2026
Conference abstractPublished 21 Nov 2016
In vivo distribution evaluation of combination of Lipo-Dox and 188Re-liposome in breast tumor model
Institute of Nuclear Energy Research, Taiwan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The aim of this study was to investigate the in vivo distribution evaluation of intravenously administrated combination of Lipo- Dox and 188Re-liposome in breast solid tumor model by biodistribution and nanoSPECT/CT studies. Female BALB/c mice were subcutaneously inoculated with 4T1 cells. At 14 days after tumor inoculation, the tumor-bearing mice were intravenously injected via tail vein with pretreated Lipo-Dox (2.5 mg/kg) or pegylation liposome on day 1 and with the 11.1 MBq/100 Ã?¼L of 188Re-liposome on day 4. Biodistribution and nanoSPECT/CT imaging were performed at 24 h after injection of 188Re-liposome. Biodistribution data of tumor sites were expressed as the percentage injected dose per gram of tissue (%ID/g). Each mouse was scanned for ~40 min by nanoSPECT/CT system. The obvious uptakes in nanoSPECT/CT images of tumor sites were observed at 24 h after injection of 188Reliposome in the pretreated Lipo-Dox group compared with that in pretreated pegylation liposome group. The tumor uptakes of the pretreated Lipo-Dox group and pegylation liposome group at 24 h after injection of 188Re-liposome were 5.8 %ID/g and 3.3 %ID/g in 4T1 solid tumor mice, respectively. In this study, mice with subcutaneous implantation of 4T1 murine breast cancer received the delivery of Lipo-Dox first, after a three-day interval, then with 188Re-liposome subsequently. The 188Re-liposome was more sufficiently delivered to tumor sites in mice with pretreated Lipo-Dox than mice with pretreated pegylation liposome. We are going to prove combination of Lipo-Dox and 188Re-liposome has the capability as potential therapeutic strategy for breast cancer in the future.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Wei Lin Lo”
- BylineArticles whose byline prints “Liang Cheng Chen”
- BylineArticles whose byline prints “Chen Hsien Liang”
- BylineArticles whose byline prints “Ming Wei Chen”
- BylineArticles whose byline prints “Cheng Hui Chuang”
- BylineArticles whose byline prints “Chih Hsien Chang”
